About (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide
(2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide (PubChem CID 51958231) has the molecular formula C17H14BrN3O2S
and a molecular weight of 404.29 g/mol. Its IUPAC name is (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide.
Analyze (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide?
The IUPAC name of (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide (CID 51958231) is (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide.
What is the SMILES notation for (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide?
The canonical SMILES for (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide is Cc1nnc(NC(=O)[C@H](Oc2cccc(Br)c2)c2ccccc2)s1.
What is the InChIKey of (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide?
The InChIKey is CZKLBHROLSIQMZ-OAHLLOKOSA-N. The full InChI is InChI=1S/C17H14BrN3O2S/c1-11-20-21-17(24-11)19-16(22)15(12-6-3-2-4-7-12)23-14-9-5-8-13(18)10-14/h2-10,15H,1H3,(H,19,21,22)/t15-/m1/s1.
What are the key properties of (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide?
(2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide has a molecular weight of 404.29 g/mol, XLogP of 4.37, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-(3-bromophenoxy)-N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-phenylacetamide is sourced from PubChem (CID 51958231), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).